Abstract
Background and study aim The “resect and discard” strategy is a new paradigm for the management of small colorectal
polyps that reduces the cost and effort related to pathological diagnosis after polypectomy.
This retrospective study aimed to clarify the clinical outcome of the “resect and
discard” strategy for small colorectal polyps.
Patients and methods The clinical records were reviewed from 501 consecutive patients who underwent the
“resect and discard” strategy for colorectal polyps smaller than 10 mm at our hospital
between January 2008 and December 2010. All colorectal lesions were evaluated onsite
under magnifying narrow-band imaging after careful conventional white-light imaging.
In cases of low grade adenoma predicted with high confidence, colonoscopists selected
the “resect and discard” option without formal histopathology. The mid-term outcomes
were evaluated to validate the curability of the “resect and discard” strategy.
Results The present study included 501 consecutive patients with 816 lesions. The mid-term
outcomes were examined for 476 (95 %) patients who received follow-up for at least
1 year after undergoing the “resect and discard” strategy. The median observation
period was 83 months (range 12 – 117 months). No patient died from colorectal cancer
related to the procedure, resulting in a disease-specific survival rate of 100 %.
There were no local and/or distant recurrences detected during follow-up.
Conclusions The “resect and discard” strategy for small colorectal polyps under strict preoperative
diagnosis achieves excellent mid-term outcome.
